NCT00762671View on ClinicalTrials.gov

Signaling Mechanisms and Vascular Function in Patients With Diabetes Mellitus

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 1999

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Type 1 Diabetes MellitusType 2 Diabetes Mellitus
Interventions
DRUG

Ebselen

150 mg BID for 2 weeks

DRUG

Placebo

Placebo 1 po BID for 2 weeks

Trial Locations (1)

02115

Brigham and Women's Hosptial, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER